Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anteris Technologies Global Corp. Capital/Financing Update 2010

Jun 30, 2010

33869_rns_2010-06-30_247a3dda-9bd8-49d9-b535-842875717580.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [595 x 64] intentionally omitted <==

Innovative BioMedical Devices

Level 11, 225 St Georges Terrace Telephone (08) 9262 6777 bioMD Limited ABN 35 088 221 078 Facsimile (08) 9322 3433 Perth, Western Australia 6000 PO Box 7209, Cloisters Square www.biomd.com.au Western Australia 6850

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 1 page

1 July 2010

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam

Re: BODOA – Options expiring 31 Dec 2011

The Directors of bioMD Ltd wish to advise that as of close of business yesterday, no further ‘piggy-back’ options (BODAZ) will be issued on the exercise of listed BODOA options.

The terms of the BODOA options are such that if any of these options were exercised before 30 June 2010, then another piggy-back option would be issued with an expiry date of 31 December 2012.

To date, 209,172 piggy back options have been issued to 16 holders. As there are fewer than 50 holders of the BODAZ options, they will remain as unlisted options.

Yours faithfully

==> picture [78 x 59] intentionally omitted <==

Caroline Bentley Company Secretary

==> picture [595 x 42] intentionally omitted <==